What initial therapy should be administered to a stable patient with myocarditis and signs of heart failure?

What initial therapy should be administered to a stable patient with myocarditis and signs of heart failure?

• A. Furosemide
• B. ECMO
• C. Methylprednisolone
• D. Intravenous immunoglobulin

Answer: (A)

In a stable patient with myocarditis accompanied by signs of heart failure, the initial therapy of choice is furosemide. This diuretic helps to address fluid overload, which is a common complication in heart failure. By promoting diuresis, furosemide reduces the excess fluid that can accumulate in the lungs and peripheral tissues, thereby alleviating symptoms such as dyspnea and edema. The use of furosemide is particularly important in this context because it directly targets the symptomatic aspects of heart failure, providing immediate relief and improving the patient’s stability. While other treatments like intravenous immunoglobulin or corticosteroids can be beneficial in specific circumstances involving inflammatory myocarditis, they typically are not first-line therapies in an acute setting focused on managing heart failure symptoms. ECMO (extracorporeal membrane oxygenation) is reserved for more severe cases where mechanical support is necessary and is usually not the initial approach for stable patients. Thus, initiating treatment with furosemide effectively addresses the immediate needs of a patient exhibiting signs of heart failure due to myocarditis, making it the appropriate choice for initial therapy.

In a stable patient with myocarditis accompanied by signs of heart failure, the initial therapy of choice is furosemide. This diuretic helps to address fluid overload, which is a common complication in heart failure. By promoting diuresis, furosemide reduces the excess fluid that can accumulate in the lungs and peripheral tissues, thereby alleviating symptoms such as dyspnea and edema.

The use of furosemide is particularly important in this context because it directly targets the symptomatic aspects of heart failure, providing immediate relief and improving the patient’s stability. While other treatments like intravenous immunoglobulin or corticosteroids can be beneficial in specific circumstances involving inflammatory myocarditis, they typically are not first-line therapies in an acute setting focused on managing heart failure symptoms. ECMO (extracorporeal membrane oxygenation) is reserved for more severe cases where mechanical support is necessary and is usually not the initial approach for stable patients.

Thus, initiating treatment with furosemide effectively addresses the immediate needs of a patient exhibiting signs of heart failure due to myocarditis, making it the appropriate choice for initial therapy.